Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Line Treatment of Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04770623
What this trial is testing

Docetaxel and Irinotecan in Gastric Cancer

Who this might be right for
Stomach CancerGastric CancerChemotherapy Effect
Menoufia University 32
Testing effectiveness (Phase 2)UnknownNCT05928897
What this trial is testing

Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab

Who this might be right for
Gastric Cancer
Xiangya Hospital of Central South University 30
Testing effectiveness (Phase 2)UnknownNCT05395780
What this trial is testing

Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Maxinovel Pty., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT04555304
What this trial is testing

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

Who this might be right for
Gastric CancerGastroesophageal Cancer
Chengdu Kanghong Biotech Co., Ltd. 81
Testing effectiveness (Phase 2)Ended earlyNCT03061708
What this trial is testing

Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy

Who this might be right for
Stomach Neoplasms
Samsung Medical Center 1
Not applicableStudy completedNCT06666582
What this trial is testing

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer Stage IVSecond-line TreatmentRamucirumab Paclitaxel
Hellenic Cooperative Oncology Group 185
Large-scale testing (Phase 3)UnknownNCT04486651
What this trial is testing

HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer

Who this might be right for
Stomach Cancer
Taizhou Hanzhong biomedical co. LTD 560
Not applicableUnknownNCT05301465
What this trial is testing

Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.

Who this might be right for
Gastric Cancer Stage IV
University of Pisa 50
Testing effectiveness (Phase 2)Study completedNCT01260701
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Gastric AdenocarcinomaGastric Intestinal Type Adenocarcinoma+2 more
National Cancer Institute (NCI) 75